Levetiracetam

Aka: Levetiracetam, Keppra

advertisement

II. Indications

  1. Status Epilepticus
  2. Seizure Prophylaxis
    1. Focal onset Seizures (FDA Approved)
    2. Juvenile Myoclonic Epilepsy (FDA approved for ages >12 years)
    3. Primary Generalized Tonic Clonic Seizures (FDA approved for ages >6 years)

III. Mechanism

  1. Broad spectrum anticonvulsant
  2. Binds glycoprotein 2A at the synaptic Vesicle and may alter Vesicle fusion
  3. May also affect gamma-aminobutyric acid (GABA)

IV. Dosing: Seizure Prophylaxis in Adults

  1. Start: 1000 mg/day orally divided twice daily
  2. Titrate every 2 weeks (increase dose by 1000 mg)
  3. Typical target dose: 3000 mg/day (or 80 mg/kg/day) divided twice daily
  4. Target serum concentration: 12 to 46 mcg/ml
  5. Maximum: 4000 mg/day
  6. Intravenous infusion dose is bioequivalent to oral dose
    1. Load: 20-30 mg/kg IV at 5 mg/kg/min

V. Dosing: Status Epilepticus

  1. Dose: 60 mg/kg IV (or 2.5 g in adults, up to 4.5 g maximum) over 5 to 15 min for single dose

VI. Adverse Effects

  1. Most common
    1. Fatigue
    2. Somnolence
    3. Dizziness
  2. Psychiatric symptoms
    1. Agitation
    2. Anxiety
    3. Depressed mood
  3. Other symptoms
    1. Irritability
    2. Rash

VII. Safety

  1. Safe in children
  2. Pregnancy Category C

VIII. References

  1. LoVecchio and Pringle (2018) Crit Dec Emerg Med 32(12): 28
  2. Liu (2017) Am Fam Physician 96(2): 87-96 [PubMed]

Images: Related links to external sites (from Bing)

These images are a random sampling from a Bing search on the term "Levetiracetam." Click on the image (or right click) to open the source website in a new browser window. Search Bing for all related images

Related Studies

Cost: Medications

levetiracetam (on 5/31/2017 at Medicaid.Gov Survey of pharmacy drug pricing)
LEVETIRACETAM 1,000 MG TABLET Generic $0.29 each
LEVETIRACETAM 100 MG/ML SOLN Generic $0.04 per ml
LEVETIRACETAM 250 MG TABLET Generic $0.09 each
LEVETIRACETAM 500 MG TABLET Generic $0.10 each
LEVETIRACETAM 750 MG TABLET Generic $0.17 each
LEVETIRACETAM ER 500 MG TABLET Generic $0.40 each
LEVETIRACETAM ER 750 MG TABLET Generic $0.54 each
keppra (on 2/22/2017 at Medicaid.Gov Survey of pharmacy drug pricing)
KEPPRA 1,000 MG TABLET Generic $0.29 each
KEPPRA 100 MG/ML ORAL SOLN Generic $0.04 per ml
KEPPRA 250 MG TABLET Generic $0.09 each
KEPPRA 500 MG TABLET Generic $0.10 each
KEPPRA 750 MG TABLET Generic $0.17 each
KEPPRA XR 500 MG TABLET Generic $0.40 each
KEPPRA XR 750 MG TABLET Generic $0.54 each
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information.

Ontology: Levetiracetam (C0377265)

Definition (NCI) A pyrrolidine with antiepileptic activity. The exact mechanism through which levetiracetam exerts its effects is unknown but does not involve inhibitory and excitatory neurotransmitter activity. Stereoselective binding of levetiracetam was confined to synaptic plasma membranes in the central nervous system with no binding occurring in peripheral tissue. Levetiracetam inhibits burst firing without affecting normal neuronal excitability, which suggests that it may selectively prevent hyper-synchronization of epileptiform burst firing and propagation of seizure activity.
Definition (NCI_NCI-GLOSS) A drug used to treat seizures (involuntary muscle movements) caused by epilepsy (a group of brain disorders). Keppra is being studied in the treatment of seizures in patients with cancer that has spread to the brain. It is a type of anticonvulsant.
Definition (PDQ) A pyrrolidine with antiepileptic activity. The exact mechanism through which levetiracetam exerts its effects is unknown but does not involve inhibitory and excitatory neurotransmitter activity. Stereoselective binding of levetiracetam was confined to synaptic plasma membranes in the central nervous system with no binding occurring in peripheral tissue. Levetiracetam inhibits burst firing without affecting normal neuronal excitability, which suggests that it may selectively prevent hyper-synchronization of epileptiform burst firing and propagation of seizure activity. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=526173&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=526173&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47581" NCI Thesaurus)
Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH C026098
SnomedCT 323049001, 116076009, 387000003
LNC LP28566-5, MTHU014314
English (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide, 1-Pyrrolidineacetamide, Alpha-ethyl-2-oxo-,(S)-, levetiracetam, (S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide, 1-pyrrolidineacetamide, alpha-ethyl-2-oxo-,(S)-, levetiracetam (medication), LEVETIRACETAM, levETIRAcetam, LevETIRAcetam, Levetiracetam, Levetiracetam (product), Levetiracetam (substance), etiracetam, S-isomer
Spanish levetiracetam (producto), levetiracetam (sustancia), levetiracetam
Derived from the NIH UMLS (Unified Medical Language System)

Ontology: Keppra (C0876060)

Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH C026098
English levetiracetam (Keppra), keppra, UCB Brand of Levetiracetam, Keppra
Derived from the NIH UMLS (Unified Medical Language System)

Related Topics in Pharmacology

advertisement

2022 Family Practice Notebook, LLC. Terms | Privacy | About | Site Map | Blog

Footer Site Logo